Related Experiment Videos
[Impact of overweight on clinical outcomes in patients undergoing coronary revascularization]
Jun-ping Kang1, Chang-sheng Ma, Qiang Lü
1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China.
Insights
Patients with heart failure undergoing coronary revascularization who are overweight or obese have a similar or better prognosis than normal-weight patients. This finding suggests that higher body mass index (BMI) does not worsen outcomes in this population.
Area of Science:
- Cardiology
- Metabolic Syndrome
- Clinical Outcomes
Context:
- Heart failure (HF) is a complex condition often associated with comorbidities.
- Coronary revascularization is a key treatment for coronary artery disease (CAD) in HF patients.
- The impact of body mass index (BMI) on outcomes after revascularization in HF patients remains an area of investigation.
Purpose:
- To investigate the association between body mass index (BMI) and clinical outcomes in patients with heart failure who underwent coronary revascularization.
- To compare the risks of total mortality, cardiac mortality, and major adverse cardiovascular and cerebrovascular events (MACCE) across different BMI categories.
Summary:
- A single-center registry analyzed 1010 heart failure patients who underwent coronary revascularization, categorized by BMI (normal, overweight, obese).
- Overweight and obese patients presented with more comorbidities, including hypertension and higher triglyceride levels.
- Multivariate analysis revealed that obese patients had a significantly decreased hazard risk for total mortality and MACCE compared to normal BMI patients.
Impact:
- The findings suggest that obesity or overweight in heart failure patients with coronary heart disease does not lead to worse prognosis after revascularization.
- This study contributes to understanding the 'obesity paradox' in cardiovascular disease.
- Results may inform clinical management and risk stratification strategies for heart failure patients undergoing revascularization.
Objectives:
To determine the impact of BMI on clinical outcome in patients with heart failure underwent coronary revascularization.
Methods:
The DESIRE-plus (Drug-Eluting Stent Impact on Revascularization-plus) was a single-center registry of coronary revascularization in our institution between July 1, 2004 and September 30, 2005. We analyzed heart failure patients with the complete data of body mass index (BMI) data from the DESIRE-plus trial and grouped them by BMI (normal BMI group, BMI < 24; overweight group, BMI 24-27.9; obesity group, BMI > or = 28). Total mortality, cardiac mortality and MACCE including death, neo-myocardial infarction, stroke, re-revascularization were recorded. We evaluated risk estimates for three bodyweight groups.
Results:
1010 patients were included in the study (295 in normal BMI group; 495 in overweight group and 220 obesity group). Median follow-up was 542 days. Overweight and obese patients were younger (59.3 +/- 10.14 years, 58.6 +/- 10.30 years vs 62.6 +/- 9.93 years, P < 0.01) and had a significantly higher incidence of hypertension (61.2, 66.8% vs 52.5%, P = 0.017), stable angina pectoris (21.2%, 23.7% vs 17.0%, P = 0.05) and higher triglyceride [(1.90 +/- 1.05) mmol/L, (2.10 +/- 1.12) mmol/L vs (1.48 +/- 0.92) mmol/L, P < 0.01)], fasting blood glucose level [(6.07 +/- 2.09) mmol/L, (5.96 +/- 1.53) mmol/L vs (5.67 +/- 1.92) mmol/L, P = 0.021), blood creatinine (84.9 +/- 21.7) micromol/L, (90.2 +/- 30.9) micromol/L vs (82.2 +/- 25.8) micromol/L, P = 0.002] compared with normal BMI patients. Multivariate Cox regression model showed obese patients had an decreased hazard risk (HR) for total mortality (0.285, 95%CI 0.104 - 0.777) and MACCE (0.596, 95%CI 0.401 - 0.885) compared with those for patients with normal BMI, overweight patients had no increased risk for total mortality (HR 0.769, 95%CI 0.442 - 1.338) and MACCE (0.998, 95%CI 0.754 - 1.322), there was hardly any significantly difference in cardiac mortality between three groups (P = 0.223).
Conclusion:
There were more risk factors in heart failure patients with coronary heart disease complicated with obesity or overweight, but the prognosis after revascularization of them is at least no worse than the normal weight coronary heart disease patients.
Related Concept Videos
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease I: Introduction
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Coronary Artery Disease V: Interprofessional Care